| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033207402 |
| P356 | DOI | 10.2165/00003088-199223050-00005 |
| P698 | PubMed publication ID | 1478006 |
| P2093 | author name string | Gómez F | |
| J. A. Armijo | |||
| F. Gómez | |||
| de Cos MA | |||
| Gómez-Ullate J | |||
| J. Gómez-Ullate | |||
| M. A. de Cos | |||
| P2860 | cites work | A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth | Q34189811 |
| Gentamicin blood levels: a guide to nephrotoxicity | Q34934750 | ||
| Prospective Comparative Study of Variable Dosage and Variable Frequency Regimens for Administration of Gentamicin | Q34948994 | ||
| Incidence of potentially toxic concentrations of gentamicin in the neonate | Q35117551 | ||
| Clinical pharmacokinetics of antibacterial drugs in neonates | Q37956835 | ||
| Clinical significance of antibiotic tissue penetration | Q38625262 | ||
| Neonatal therapeutic drug monitoring--its clinical relevance | Q38654927 | ||
| Drug level monitoring in paediatric practice | Q38914642 | ||
| Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations | Q39637020 | ||
| Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II). | Q39654030 | ||
| Aminoglycoside toxicity in infants and children | Q39738115 | ||
| Estimation of gentamicin clearance and volume of distribution in neonates and young children | Q41894975 | ||
| Aminoglycoside-related nephrotoxicity in the premature newborn | Q42247730 | ||
| Gentamicin dosage in preterm and term neonates | Q42726622 | ||
| Optimization of gentamicin therapy in very low birth weight infants | Q43906829 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Developmental patterns of renal functional maturation compared in the human neonate | Q44532477 | ||
| Is monitoring plasma levels of netilmicin necessary in neonates? | Q44807675 | ||
| Gentamicin tissue accumulation and nephrotoxic reactions | Q44893689 | ||
| Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin | Q46984010 | ||
| Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants | Q47204812 | ||
| Pharmacologic evaluation of gentamicin in newborn infants | Q47737176 | ||
| Gentamicin in newborn infants. Comparison of intramuscular and intravenous administration | Q47919361 | ||
| Freedom from ototoxicity in aminoglycoside treated neonates: A mistaken notion | Q49141691 | ||
| Aminoglycoside dosing in pediatric patients. | Q52542659 | ||
| The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. | Q52695343 | ||
| Reappraisal of kanamycin usage in neonates | Q66894770 | ||
| Comparison of gentamicin assays | Q67295644 | ||
| Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations | Q67919867 | ||
| Gentamicin monitoring in neonates | Q67985938 | ||
| Monitoring serum levels of gentamicin to develop a new regimen for gentamicin dosage in newborns | Q68022538 | ||
| Early neonatal drug utilization in preterm newborns in neonatal intensive care units. Italian Collaborative Group on Preterm Delivery | Q69919595 | ||
| The need for a loading dose of gentamicin in neonates | Q69937953 | ||
| Postconceptional age and gentamicin elimination half-life | Q70062226 | ||
| Gentamicin kinetics in the neonate | Q70095077 | ||
| [Relevance and applications of systematic quantitative determinations of gentamicin during the neonatal period (author's transl)] | Q70256843 | ||
| Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective | Q70309773 | ||
| High gentamicin trough concentrations in neonates of less than 28 weeks gestational age | Q70540197 | ||
| Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates | Q71271203 | ||
| Development of glomerular filtration rate and excretion of beta 2-microglobulin in neonates during gentamicin treatment | Q72694223 | ||
| Tobramycin and gentamicin are equally safe for neonates: results of a double-blind randomized trial with quantitative assessment of renal function | Q73421962 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gentamicin | Q422482 |
| P304 | page(s) | 391-401 | |
| P577 | publication date | 1992-11-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Time course of trough serum gentamicin concentrations in preterm and term neonates | |
| P478 | volume | 23 |
| Q52016990 | A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. |
| Q38240055 | Dosage individualization in children: integration of pharmacometrics in clinical practice |
| Q58805183 | Gentamicin dosing in neonates: evaluation of a dosing protocol |
| Q36051172 | Gentamicin in neonates at risk for sepsis - peak serum concentrations are not necessary |
| Q71952604 | Optimal gentamicin dosing in neonates |
| Q37621548 | Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates |
| Q38215682 | Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. |
| Q38696468 | Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates |
| Q42742563 | Single or multiple daily doses of aminoglycosides. More details needed of treatment in neonates and young children |
| Q42666715 | Tobramycin population pharmacokinetics in neonates. |
Search more.